Immunovia AB (IMMNOV) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, welcome to the Immunovia Q1 Interim Report 2026 conference call. I'm Lorenzo, the chorus call operator. I would like to remind you that all participants will be in listen-only mode and the conference is being recorded. The presentation will be followed by a Q&A session. You can register for questions at any time by pressing star and 1 on your telephone. For operator assistance, please press star and 0. The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Peter Hongard. Please go ahead. Thank you. Yeah, my name is, as introduced, Peter Hongard. I am the chairman of the board. And if you could forward to the first slide, please. It's a pleasure for me to participate in this webcast today, which we're going to do a little bit differently. The difference is that we're going to provide you with somewhat more forward-looking statements and give you an idea about the interesting and exciting milestones which Immunovia is going to meet over the next year or so towards being a full-fledged commercial company. And in order to incentivize this, we have also put an incentivizing scheme in place both for management but also for the board itself. And I'll come back to that a little later in the presentation. But first, handing over to Jeff to explain more details about the company today and the plans going forward. Jeff, please. Thanks very much for the introduction, Peter, and great to have you on the call today. I'd like to start by talking about our plan for 2026 and really what extends beyond that as well. As we do that, I'll cover key results from the first quarter as we think about our focus areas for this year and how we're achieving our goals and objectives for those areas. We've defined thre...